C S Sweet - JoVE Visualize

Showing results (51-60 of 64) with videos related to

Pageof 7

Sort By:

Journal of Medicinal Chemistry|January 1, 1981

2-(Aminomethyl)phenols, a new class of saluretic agents. 2. Synthesis and pharmacological properties of the 5-aza isostere of 2-(aminomethyl)-4-(1,1-dimethylethyl)-6-iodophenolG E Stokker, R L Smith, E J Cragoe, et al.

Hypertension (Dallas, Tex. : 1979)|June 1, 1995

A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertensionA H Gradman, K E Arcuri, A I Goldberg, et al.

Hypertension (Dallas, Tex. : 1979)|May 1, 1985

Comparison of renin and converting enzyme inhibition in sodium-deficient dogsE H Blaine, B J Nelson, A A Seymour, et al.

Journal of Medicinal Chemistry|January 1, 1980

Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridineJ J Baldwin, E L Engelhardt, R Hirschmann, et al.

The Journal of Pharmacology and Experimental Therapeutics|January 1, 1979

Diuretic and antihypertensive effects of 2-aminoethyl-4-(1,1-dimethylethyl)-6-iodophenol hydrochloride (MK-447)A Scriabine, L S Watson, H F Russo, et al.

Journal of Medicinal Chemistry|June 1, 1984

3-Hydroxy-alpha-methyltyrosine progenitors: synthesis and evaluation of some (2-oxo-1,3-dioxol-4-yl)methyl estersW S Saari, W Halczenko, D W Cochran, et al.

Journal of Medicinal Chemistry|April 1, 1983

2-(Aminomethyl)phenols, a new class of saluretic agents. 6. Effects of N,O-spiroannulation and subsequent quaternizationG E Stokker, E M Schultz, R L Smith, et al.

Journal of Medicinal Chemistry|June 1, 1979

beta-Adrenergic blocking agents with acute antihypertensive activityJ J Baldwin, E L Engelhardt, R Hirschmann, et al.

The Journal of Pharmacology and Experimental Therapeutics|July 1, 1992

In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonistP K Siegl, R S Chang, N B Mantlo, et al.

The Journal of Pharmacology and Experimental Therapeutics|March 1, 1981

Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivoD M Gross, C S Sweet, E H Ulm, et al.

Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:

Pageof 7

Journal of Medicinal Chemistry|January 1, 1981

2-(Aminomethyl)phenols, a new class of saluretic agents. 2. Synthesis and pharmacological properties of the 5-aza isostere of 2-(aminomethyl)-4-(1,1-dimethylethyl)-6-iodophenolG E Stokker, R L Smith, E J Cragoe, et al.

Hypertension (Dallas, Tex. : 1979)|June 1, 1995

A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertensionA H Gradman, K E Arcuri, A I Goldberg, et al.

Hypertension (Dallas, Tex. : 1979)|May 1, 1985

Comparison of renin and converting enzyme inhibition in sodium-deficient dogsE H Blaine, B J Nelson, A A Seymour, et al.

Journal of Medicinal Chemistry|January 1, 1980

Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridineJ J Baldwin, E L Engelhardt, R Hirschmann, et al.

The Journal of Pharmacology and Experimental Therapeutics|January 1, 1979

Diuretic and antihypertensive effects of 2-aminoethyl-4-(1,1-dimethylethyl)-6-iodophenol hydrochloride (MK-447)A Scriabine, L S Watson, H F Russo, et al.

Journal of Medicinal Chemistry|June 1, 1984

3-Hydroxy-alpha-methyltyrosine progenitors: synthesis and evaluation of some (2-oxo-1,3-dioxol-4-yl)methyl estersW S Saari, W Halczenko, D W Cochran, et al.

Journal of Medicinal Chemistry|April 1, 1983

2-(Aminomethyl)phenols, a new class of saluretic agents. 6. Effects of N,O-spiroannulation and subsequent quaternizationG E Stokker, E M Schultz, R L Smith, et al.

Journal of Medicinal Chemistry|June 1, 1979

beta-Adrenergic blocking agents with acute antihypertensive activityJ J Baldwin, E L Engelhardt, R Hirschmann, et al.

The Journal of Pharmacology and Experimental Therapeutics|July 1, 1992

In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonistP K Siegl, R S Chang, N B Mantlo, et al.

The Journal of Pharmacology and Experimental Therapeutics|March 1, 1981

Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivoD M Gross, C S Sweet, E H Ulm, et al.

Pageof 7